|Bid||1.0800 x 300|
|Ask||1.1000 x 200|
|Day's Range||1.0600 - 1.0958|
|52 Week Range||1.0000 - 3.6500|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
We are initiating coverage of Midatech Pharma Plc (NASDAQ:PLC) with a $6.00 valuation. MIdatech is a U.K. based international specialty pharmaceutical company focused on oncology and other therapeutic areas. The company has three proprietary drug delivery technologies: Q-Sphera for sustained release of already marketed products, Midacore gold nanoparticles (GNP) for targeted delivery, and Nano Inclusion (NI) for local delivery.
Midatech Pharma Plc (AIM:MTPH), a biotechnology company based in United Kingdom, saw significant share price volatility over the past couple of months on the AIM, rising to the highs ofRead More...